Pharmacokinetics of Soybean Isoflavones in Plasma, Urine and Feces of Men after Ingestion of 60 g Baked Soybean Powder (Kinako)
Open Access
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Nutrition
- Vol. 128 (10) , 1710-1715
- https://doi.org/10.1093/jn/128.10.1710
Abstract
To take advantage of the various pharmacologic activities of soy bean isoflavones, more detailed studies of the absorption and excretion rates of these compounds in humans and subsequent evaluation of their bioavailabilities are required. We conducted a pharmacokinetic study of soybean isoflavones in seven healthy male volunteers. After ingestion of 60 g of kinako (baked soybean powder, containing 103 μmol daidzein and 112 μmol genistein), changes of the isoflavone and metabolite concentrations in plasma, urine and feces were measured by gas chromatography-mass spectrometry. The plasma concentration of genistein increased after 2 h and reached its highest value of 2.44 ± 0.65 μmol/L 6 h later. The plasma concentration of daidzein peaked at 1.56 ± 0.34 μmol/L at the same time, but it was always lower than that of genistein. Peak plasma concentration of O-desmethylangolensin (O-DMA) and equol appeared after the daidzein peak in four and two subjects, respectively. In contrast with plasma, daidzein was the main component in urine. Urinary daidzein excretion started to increase shortly after the rise in its plasma concentration and reached 2.4 μmol/h 8 h after ingestion of kinako. Genistein excretion in urine paralleled that of daidzein, but the value at 6 h was about half (1.1 μmol/h). The majority of ingested isoflavones after ingestion of kinako were recovered on d 2 or 3 in the feces. Total recovery of daidzein, O-DMA and equol from urine and feces was 54.7%, calculated from daidzein intake; 20.1% of administered genistein was recovered as genistein. The half-lives of plasma genistein and daidzein were 8.36 and 5.79 h, respectively. The individual plasma and urinary concentrations of equol and O-DMA were quite variable; subjects were classified as high and low metabolizers. The high plasma concentration of isoflavones for at least several hours after a single ingestion of soy protein suggests that these compounds may interact with macromolecules and have biological effects.Keywords
This publication has 32 references indexed in Scilit:
- A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoidsPublished by Elsevier ,2000
- Short-term Effects of Phytoestrogen-rich Diet on Postmenopausal WomenMenopause, 1997
- Urinary isoflavonoid phytoestrogen and lignan Excretion After Consumption of Fermented and Unfermented Soy ProductsJournal of the American Dietetic Association, 1995
- Lignan and isoflavonoid conjugates in human urineThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Isoflavone Content in Commercial Soybean FoodsJournal of Agricultural and Food Chemistry, 1994
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994
- Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG)Journal of Steroid Biochemistry, 1987
- Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual dietsJournal of Steroid Biochemistry, 1986
- Soybean isoflavones: effect of environment and variety on compositionJournal of Agricultural and Food Chemistry, 1983
- Genistin (an Isoflavone Glucoside) and its Aglucone, Genistein, from SoybeansJournal of the American Chemical Society, 1941